These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23760187)

  • 1. Mass drug administration for the elimination of lymphatic filariasis--Port-au-Prince, Haiti, 2011-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(23):466-8. PubMed ID: 23760187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards elimination of lymphatic filariasis in the Americas region.
    Fontes G; da Rocha EMM; Scholte RGC; Nicholls RS
    Int Health; 2020 Dec; 13(Suppl 1):S33-S38. PubMed ID: 33349876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of stakeholder experience and organizational learning in declining mass drug administration coverage for lymphatic filariasis in Port-au-Prince, Haiti: A case study.
    Wodnik BK; Louis DH; Joseph M; Wilkers LT; Landskroener SD; Desir L; Lemoine JF; Lavery JV
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008318. PubMed ID: 32469860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control.
    Njenga SM; Mwandawiro CS; Wamae CN; Mukoko DA; Omar AA; Shimada M; Bockarie MJ; Molyneux DH
    Parasit Vectors; 2011 May; 4():90. PubMed ID: 21612649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
    Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of malaria and lymphatic filariasis in bateyes of the Dominican Republic.
    Keys HM; Noland GS; De Rochars MB; Blount S; Gonzales M
    Infect Dis Poverty; 2019 May; 8(1):39. PubMed ID: 31130142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.
    Antony Oliver MC; Graham M; Gass KM; Medley GF; Clark J; Davis EL; Reimer LJ; King JD; Pouwels KB; Hollingsworth TD
    Clin Infect Dis; 2024 Apr; 78(Supplement_2):S160-S168. PubMed ID: 38662697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
    Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
    Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.
    Boyd A; Won KY; McClintock SK; Donovan CV; Laney SJ; Williams SA; Pilotte N; Streit TG; Beau de Rochars MV; Lammie PJ
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e640. PubMed ID: 20351776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar.
    Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ
    Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
    Richards FO; Eigege A; Miri ES; Kal A; Umaru J; Pam D; Rakers LJ; Sambo Y; Danboyi J; Ibrahim B; Adelamo SE; Ogah G; Goshit D; Oyenekan OK; Mathieu E; Withers PC; Saka YA; Jiya J; Hopkins DR
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1346. PubMed ID: 22022627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
    de Souza DK; Gass K; Otchere J; Htet YM; Asiedu O; Marfo B; Biritwum NK; Boakye DA; Ahorlu CS
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008306. PubMed ID: 32407319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.
    Abd Elaziz KM; El-Setouhy M; Bradley MH; Ramzy RM; Weil GJ
    Am J Trop Med Hyg; 2013 Aug; 89(2):260-4. PubMed ID: 23751402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(29):989-91. PubMed ID: 21796097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.
    Vaishnav KG; Desai HS; Srivastava PK; Joshi PT; Kurian G; Thakor HG; Dhariwal AC
    J Commun Dis; 2012 Dec; 44(4):251-9. PubMed ID: 25145075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.